Indivior Pharmaceuticals, Inc.

LSE:INDV Stock Report

Market Cap: UK£2.1b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Indivior Future Growth

Future criteria checks 4/6

Indivior's revenue is forecast to decline at 0.5% per annum while its annual earnings are expected to grow at 66.7% per year. EPS is expected to grow by 65.5% per annum. Return on equity is forecast to be 256.6% in 3 years.

Key information

66.7%

Earnings growth rate

65.52%

EPS growth rate

Pharmaceuticals earnings growth10.3%
Revenue growth rate-0.5%
Future return on equity256.65%
Analyst coverage

Good

Last updated25 Jul 2025

Recent future growth updates

Analysis Article • Apr 28

Results: Indivior PLC Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Indivior PLC ( LON:INDV ) came out with a strong set of quarterly numbers that could potentially lead to a...

Recent updates

Analysis Article • May 23

Indivior PLC (LON:INDV) Held Back By Insufficient Growth Even After Shares Climb 26%

Indivior PLC ( LON:INDV ) shareholders would be excited to see that the share price has had a great month, posting a...
User avatar
New Narrative • May 06

SUBLOCADE Investments Will Improve Patient And Physician Experience

Commercial investments and label updates for SUBLOCADE are expected to boost revenue growth and enhance patient and physician experience.
Analysis Article • Apr 28

Results: Indivior PLC Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Indivior PLC ( LON:INDV ) came out with a strong set of quarterly numbers that could potentially lead to a...
Analysis Article • Feb 21

The Market Doesn't Like What It Sees From Indivior PLC's (LON:INDV) Revenues Yet As Shares Tumble 26%

Indivior PLC ( LON:INDV ) shareholders won't be pleased to see that the share price has had a very rough month...
Analysis Article • Nov 15

A Piece Of The Puzzle Missing From Indivior PLC's (LON:INDV) 35% Share Price Climb

Those holding Indivior PLC ( LON:INDV ) shares would be relieved that the share price has rebounded 35% in the last...
Analysis Article • Sep 24

Positive Sentiment Still Eludes Indivior PLC (LON:INDV) Following 26% Share Price Slump

To the annoyance of some shareholders, Indivior PLC ( LON:INDV ) shares are down a considerable 26% in the last month...
Analysis Article • Aug 09

Indivior PLC's (LON:INDV) Shares Leap 37% Yet They're Still Not Telling The Full Story

Indivior PLC ( LON:INDV ) shareholders are no doubt pleased to see that the share price has bounced 37% in the last...
Analysis Article • May 29

Indivior PLC's (LON:INDV) Shares Not Telling The Full Story

With a price-to-sales (or "P/S") ratio of 2.2x Indivior PLC ( LON:INDV ) may be sending bullish signals at the moment...
Analysis Article • May 03

Shareholders May Not Be So Generous With Indivior PLC's (LON:INDV) CEO Compensation And Here's Why

Key Insights Indivior will host its Annual General Meeting on 9th of May CEO Mark Crossley's total compensation...
Analysis Article • Apr 10

We Think Indivior (LON:INDV) Can Stay On Top Of Its Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Feb 28

The Market Lifts Indivior PLC (LON:INDV) Shares 26% But It Can Do More

Indivior PLC ( LON:INDV ) shares have continued their recent momentum with a 26% gain in the last month alone. Looking...
Analysis Article • Dec 11

Are Investors Undervaluing Indivior PLC (LON:INDV) By 50%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Indivior fair value estimate is UK£23.62 Indivior is estimated...
Analysis Article • Oct 15

We Think Indivior (LON:INDV) Can Stay On Top Of Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Jun 27

We Think Indivior (LON:INDV) Can Stay On Top Of Its Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Mar 29

Indivior (LON:INDV) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Earnings and Revenue Growth Forecasts

LSE:INDV - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,129209-106125
12/31/20261,054166711266
12/31/20251,020137641566
3/31/20251,170-62102135N/A
12/31/20241,188-48-823N/A
9/30/20241,18312-256-222N/A
6/30/20241,147-127-262-209N/A
3/31/20241,12419-366-316N/A
12/31/20231,0932-368-315N/A
9/30/20231,042-235-89-52N/A
6/30/20231,002-59-22-11N/A
3/31/2023947-502335N/A
12/31/2022901-44-9-4N/A
9/30/2022882166176181N/A
6/30/2022838152160145N/A
3/31/2022818166175189N/A
12/31/2021791205339353N/A
9/30/2021753156101115N/A
6/30/202172513981115N/A
3/31/2021674953942N/A
12/31/2020647-148-197-193N/A
9/30/2020595-190-84-82N/A
6/30/2020634-152-70-69N/A
3/31/2020700-95-131-130N/A
12/31/2019785134148151N/A
9/30/2019889213217200N/A
6/30/2019935254281275N/A
3/31/2019988248401413N/A
12/31/20181,005275N/A303N/A
9/30/20181,033106N/A276N/A
6/30/20181,06467N/A210N/A
3/31/20181,08371N/A260N/A
12/31/20171,09358N/A295N/A
9/30/20171,087281N/A360N/A
6/30/20171,08081N/A409N/A
3/31/20171,06565N/A370N/A
12/31/20161,05835N/A407N/A
9/30/20161,047-6N/A326N/A
6/30/20161,028191N/A283N/A
3/31/20161,021201N/A252N/A
12/31/20151,014228N/A320N/A
9/30/20151,037268N/A300N/A
6/30/20151,058314N/A369N/A
3/31/20151,085361N/A530N/A
12/31/20141,115403N/A440N/A
9/30/20141,147443N/A572N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: INDV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: INDV is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: INDV is expected to become profitable in the next 3 years.

Revenue vs Market: INDV's revenue is expected to decline over the next 3 years (-0.5% per year).

High Growth Revenue: INDV's revenue is forecast to decline over the next 3 years (-0.5% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: INDV's Return on Equity is forecast to be very high in 3 years time (256.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/26 09:56
End of Day Share Price 2025/07/24 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Indivior Pharmaceuticals, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Glen SantangeloBarclays
Graham Glyn ParryBofA Global Research
Chase KnickerbockerCraig-Hallum Capital Group LLC